Interestingly, VEGF ligand has been found to be mutated in colon cancer, indicating that VEGF is not only important for tumour development and progression but it can also act as a therapeutic target molecule for colon cancer. The gene discussed is VEGFA; the disease is malignant colon neoplasm.